Regarding biological implications of CD8+HLA-DR+ cells, we observed that these Treg cells were present in TILs of patients with NSCLC at even higher frequencies than CD4+FOXP3+ Treg cells (5). This evidence concerns the gene CD4 and non-small cell lung carcinoma.